Get started
Author

A Adeyemi

Observed name: A. Adeyemi
ORCID: 0009-0004-6688-7799
Observed ORCID: 0009-0004-6688-7799
OpenAlex ID: A5112568661
MSR8 Psychometric Validation of the PAINS-pNF Target Plexiform Neurofibroma (PN) Pain Severity Score Using Data From KOMET (NCT04924608)
2024 · A Adeyemi, P Wolters, et al. · Value in Health · 3
PDF
MSR190 Psychometric Analysis of the Patient-Reported Plexiform Neurofibromas Quality of Life Measure Using KOMET Study Data
2024 · A Adeyemi, J Norquist, et al. · Value in Health · 1
POSC28 Systematic Literature Review of Second-LINE Treatments for SMALL-Cell LUNG Cancer
2022 · R Hanvesakul, B Rengarajan, et al. · Value in Health
PND93 First LINE Treatment with Natalizumab Reduces Healthcare Resource Use and Work Productivity and Activity Impairment in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Compared to Natalizumab Delayed Use
2020 · C. Acosta, E. Jones, et al. · Value in Health
Pmu19 First Line Treatment With Natalizumab Reduces Healthcare Resource Use and Impairment of Work Productivity and Activity Impairment in Relapsing-remitting Multiple Sclerosis (rrms) Patients Compared to Natalizumab Delayed Use
2020 · C. Acosta, E. Jones, et al. · Value in Health
Diagnosis and management of celiac disease
2015 · A Adeyemi, Irina Zelena · Kharkiv National Medical University Repository (Kharkiv National Medical University)
Works count: 6
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type